GLP-1(736)amide, GIP(142), and exendin-4, or liraglutide, and a low dose of vidagliptin (to prevent incretins degradation) were added to the human peripheral mononuclear cells cultures and incubated for a week
Given that GLP-1 biology is complex and may involve several parallel mechanisms with or without transmembrane receptors (31) and distinct metabolites (32), we chose to next focus on the direct actions of the single metabolite GLP-1(2836) using in-depth in vitro studies into its cellular and molecular actions
Gastrointestinal effectsparticularly nausea, vomiting, diarrhea, and constipationaffect 40-50% of patients, especially during dose escalation
Review of Long-Term Effects: The FDA assesses data on the long-term use of oral semaglutide, including its effects on weight loss sustainability, potential health benefits, and risks over extended periods
Insulin and neurodegenerative disease: shared and specific mechanisms
10.1152/ajpgi.00342.2010 19